The lung cancer multidisciplinary team (MDT) is critical to best practice and better outcomes in patients with stage lll non-small cell lung cancer (NSCLC). However, according to a review article in the Asia-Pacific Journal of Clinical Oncology, only about half of patients are receiving this level of care in Australia. “Patients with stage III NSCLC ...
Already a member?
Enter your email to keep reading.